- en: Better A/B Testing with Survival Analysis
  id: totrans-0
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: ä½¿ç”¨ç”Ÿå­˜åˆ†ææ”¹å–„ A/B æµ‹è¯•
- en: åŸæ–‡ï¼š[https://towardsdatascience.com/better-a-b-testing-with-survival-analysis-6205c3a2dc51?source=collection_archive---------12-----------------------#2024-07-31](https://towardsdatascience.com/better-a-b-testing-with-survival-analysis-6205c3a2dc51?source=collection_archive---------12-----------------------#2024-07-31)
  id: totrans-1
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: åŸæ–‡ï¼š[https://towardsdatascience.com/better-a-b-testing-with-survival-analysis-6205c3a2dc51?source=collection_archive---------12-----------------------#2024-07-31](https://towardsdatascience.com/better-a-b-testing-with-survival-analysis-6205c3a2dc51?source=collection_archive---------12-----------------------#2024-07-31)
- en: '*When running experiments â€” donâ€™t forget to bring your survival kit*'
  id: totrans-2
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: '*è¿›è¡Œå®éªŒæ—¶â€”â€”åˆ«å¿˜äº†å¸¦ä¸Šä½ çš„ç”Ÿå­˜å·¥å…·åŒ…*'
- en: '[](https://iyarlin.medium.com/?source=post_page---byline--6205c3a2dc51--------------------------------)[![Iyar
    Lin](../Images/8d27b185b273b7ea035250cdbd3eddbf.png)](https://iyarlin.medium.com/?source=post_page---byline--6205c3a2dc51--------------------------------)[](https://towardsdatascience.com/?source=post_page---byline--6205c3a2dc51--------------------------------)[![Towards
    Data Science](../Images/a6ff2676ffcc0c7aad8aaf1d79379785.png)](https://towardsdatascience.com/?source=post_page---byline--6205c3a2dc51--------------------------------)
    [Iyar Lin](https://iyarlin.medium.com/?source=post_page---byline--6205c3a2dc51--------------------------------)'
  id: totrans-3
  prefs: []
  type: TYPE_NORMAL
  zh: '[](https://iyarlin.medium.com/?source=post_page---byline--6205c3a2dc51--------------------------------)[![Iyar
    Lin](../Images/8d27b185b273b7ea035250cdbd3eddbf.png)](https://iyarlin.medium.com/?source=post_page---byline--6205c3a2dc51--------------------------------)[](https://towardsdatascience.com/?source=post_page---byline--6205c3a2dc51--------------------------------)[![Towards
    Data Science](../Images/a6ff2676ffcc0c7aad8aaf1d79379785.png)](https://towardsdatascience.com/?source=post_page---byline--6205c3a2dc51--------------------------------)
    [Iyar Lin](https://iyarlin.medium.com/?source=post_page---byline--6205c3a2dc51--------------------------------)'
- en: Â·Published in [Towards Data Science](https://towardsdatascience.com/?source=post_page---byline--6205c3a2dc51--------------------------------)
    Â·5 min readÂ·Jul 31, 2024
  id: totrans-4
  prefs: []
  type: TYPE_NORMAL
  zh: Â·å‘å¸ƒäº [Towards Data Science](https://towardsdatascience.com/?source=post_page---byline--6205c3a2dc51--------------------------------)
    Â·é˜…è¯»æ—¶é—´ï¼š5åˆ†é’ŸÂ·2024å¹´7æœˆ31æ—¥
- en: --
  id: totrans-5
  prefs: []
  type: TYPE_NORMAL
  zh: --
- en: '![](../Images/56414e53785ef2532485fc1ca1f6cf4b.png)'
  id: totrans-6
  prefs: []
  type: TYPE_IMG
  zh: '![](../Images/56414e53785ef2532485fc1ca1f6cf4b.png)'
- en: Image by author, using DALL-E 3
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: å›¾ç‰‡æ¥æºï¼šä½œè€…ï¼Œä½¿ç”¨ DALL-E 3
- en: Iâ€™ve already made the case in several blog posts ([Here](https://iyarlin.github.io/2022/06/08/better_churn_modeling/),
    [here](https://iyarlin.github.io/2022/10/31/better_churn_modeling_part_2/) and
    [here](https://www.linkedin.com/pulse/better-churn-prediction-part-3-iyar-lin-ov5af/))
    that using survival analysis can improve churn prediction.
  id: totrans-8
  prefs: []
  type: TYPE_NORMAL
  zh: æˆ‘åœ¨å‡ ç¯‡åšå®¢ä¸­å·²ç»é˜è¿°è¿‡è¿™ä¸ªè§‚ç‚¹ï¼ˆ[è¿™é‡Œ](https://iyarlin.github.io/2022/06/08/better_churn_modeling/)ã€[è¿™é‡Œ](https://iyarlin.github.io/2022/10/31/better_churn_modeling_part_2/)
    å’Œ [è¿™é‡Œ](https://www.linkedin.com/pulse/better-churn-prediction-part-3-iyar-lin-ov5af/)ï¼‰ï¼Œå³ä½¿ç”¨ç”Ÿå­˜åˆ†æå¯ä»¥æ”¹å–„æµå¤±é¢„æµ‹ã€‚
- en: 'In this blog post Iâ€™ll show another use case where survival analysis can improve
    on common practices: A/B testing!'
  id: totrans-9
  prefs: []
  type: TYPE_NORMAL
  zh: åœ¨è¿™ç¯‡åšå®¢ä¸­ï¼Œæˆ‘å°†å±•ç¤ºç”Ÿå­˜åˆ†æå¦‚ä½•åœ¨å¸¸è§çš„å®è·µä¸­å‘æŒ¥ä½œç”¨çš„å¦ä¸€ä¸ªæ¡ˆä¾‹ï¼šA/B æµ‹è¯•ï¼
- en: The problems with common A/B testing practices
  id: totrans-10
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: å¸¸è§ A/B æµ‹è¯•å®è·µä¸­çš„é—®é¢˜
- en: Usually when running an A/B test analysts assign users randomly to variants
    over time and measure conversion rate as the ratio between the number of conversions
    and the number of users in each variant. Users who just entered the test and those
    who are in the test for 2 weeks get the same weight.
  id: totrans-11
  prefs: []
  type: TYPE_NORMAL
  zh: é€šå¸¸åœ¨è¿›è¡Œ A/B æµ‹è¯•æ—¶ï¼Œåˆ†æå¸ˆä¼šå°†ç”¨æˆ·éšæœºåˆ†é…åˆ°ä¸åŒçš„å˜ä½“ï¼Œå¹¶æ ¹æ®æ¯ä¸ªå˜ä½“ä¸­çš„è½¬åŒ–æ•°é‡ä¸ç”¨æˆ·æ•°é‡çš„æ¯”ä¾‹æ¥è¡¡é‡è½¬åŒ–ç‡ã€‚åˆšè¿›å…¥æµ‹è¯•çš„ç”¨æˆ·å’Œåœ¨æµ‹è¯•ä¸­å·²æœ‰ä¸¤å‘¨çš„ç”¨æˆ·ä¼šè¢«èµ‹äºˆç›¸åŒçš„æƒé‡ã€‚
- en: This can be enough for cases where a conversion either happens or not within
    a short time frame after assignment to a variant (e.g. Finishing an on-boarding
    flow).
  id: totrans-12
  prefs: []
  type: TYPE_NORMAL
  zh: è¿™ç§æ–¹æ³•å¯¹äºé‚£äº›åœ¨åˆ†é…åˆ°å˜ä½“åçŸ­æ—¶é—´å†…å‘ç”Ÿè½¬åŒ–æˆ–ä¸å‘ç”Ÿè½¬åŒ–çš„æƒ…å†µï¼ˆä¾‹å¦‚å®Œæˆå…¥èŒæµç¨‹ï¼‰æ˜¯è¶³å¤Ÿçš„ã€‚
- en: There are however many instances where conversions are spread over a longer
    time frame. One example would be first order after visiting a site landing page.
    Such conversions may happen within minutes, but a large portion could still happen
    days after the first visit.
  id: totrans-13
  prefs: []
  type: TYPE_NORMAL
  zh: ç„¶è€Œï¼Œå¾ˆå¤šæ—¶å€™è½¬åŒ–æ˜¯åˆ†å¸ƒåœ¨è¾ƒé•¿çš„æ—¶é—´æ¡†æ¶å†…ã€‚ä¾‹å¦‚ï¼Œç¬¬ä¸€æ¬¡è®¿é—®ç½‘ç«™ç€é™†é¡µåçš„é¦–æ¬¡è®¢å•ã€‚è¿™æ ·çš„è½¬åŒ–å¯èƒ½åœ¨å‡ åˆ†é’Ÿå†…å‘ç”Ÿï¼Œä½†å¾ˆå¤§ä¸€éƒ¨åˆ†å¯èƒ½ä¼šåœ¨é¦–æ¬¡è®¿é—®åå‡ å¤©å‘ç”Ÿã€‚
- en: In such cases the business KPIs are usually â€œboundedâ€ to a certain period â€”
    e.g. â€œconversion within 7 daysâ€ or â€œchurn within 1 monthâ€.
  id: totrans-14
  prefs: []
  type: TYPE_NORMAL
  zh: åœ¨è¿™ç§æƒ…å†µä¸‹ï¼Œä¸šåŠ¡ KPI é€šå¸¸ä¼šè¢«â€œé™å®šâ€åœ¨æŸä¸ªç‰¹å®šçš„æ—¶é—´æ®µå†…â€”â€”ä¾‹å¦‚ï¼Œâ€œ7å¤©å†…çš„è½¬åŒ–â€æˆ–â€œ1ä¸ªæœˆå†…çš„æµå¤±â€ã€‚
- en: 'In those instances measuring conversions without considering their timing has
    2 major flaws:'
  id: totrans-15
  prefs: []
  type: TYPE_NORMAL
  zh: åœ¨è¿™äº›æƒ…å†µä¸‹ï¼Œä¸è€ƒè™‘æ—¶é—´å› ç´ åœ°è¡¡é‡è½¬åŒ–ç‡æœ‰ä¸¤ä¸ªä¸»è¦ç¼ºé™·ï¼š
- en: It makes the statistic weâ€™re measuring unintelligible â€” Average conversions
    at any point in time does not translate to any bounded metric. In fact as the
    test keeps running â€” conversion rates will increase just because users get more
    time to convert. The experiment results will be thus hard to relate to the business
    KPIs.
  id: totrans-16
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: å®ƒä½¿æˆ‘ä»¬æ‰€æµ‹é‡çš„ç»Ÿè®¡é‡å˜å¾—éš¾ä»¥ç†è§£â€”â€”ä»»ä½•æ—¶é—´ç‚¹çš„å¹³å‡è½¬æ¢ç‡æ— æ³•è½¬æ¢ä¸ºä»»ä½•æœ‰ç•Œçš„åº¦é‡ã€‚äº‹å®ä¸Šï¼Œéšç€æµ‹è¯•çš„ç»§ç»­ï¼Œè½¬æ¢ç‡å°†ä¼šå¢åŠ ï¼Œä»…ä»…æ˜¯å› ä¸ºç”¨æˆ·æœ‰æ›´å¤šçš„æ—¶é—´è¿›è¡Œè½¬æ¢ã€‚å› æ­¤ï¼Œå®éªŒç»“æœå°†éš¾ä»¥ä¸ä¸šåŠ¡KPIå…³è”ã€‚
- en: It discards the timing information which could lead to reduced power compared
    with methods that do take conversion timing into account.
  id: totrans-17
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: å®ƒä¸¢å¼ƒäº†å¯èƒ½å½±å“ç»“æœçš„æ—¶é—´ä¿¡æ¯ï¼Œç›¸æ¯”äºè€ƒè™‘äº†è½¬æ¢æ—¶é—´çš„å…¶ä»–æ–¹æ³•ï¼Œè¿™å¯èƒ½å¯¼è‡´åŠŸæ•ˆé™ä½ã€‚
- en: 'To demonstrate point #2 weâ€™ll run a small simulation study'
  id: totrans-18
  prefs: []
  type: TYPE_NORMAL
  zh: ä¸ºäº†å±•ç¤ºç¬¬2ç‚¹ï¼Œæˆ‘ä»¬å°†è¿è¡Œä¸€ä¸ªå°çš„æ¨¡æ‹Ÿç ”ç©¶
- en: Weâ€™ll have users join the experiment randomly over a 30 day period. Usersâ€™ time
    to convert will be simulated from a Weibull distribution with scale ğœ=30,000,
    ğ›¼_ctrl=0.18 for the control group and ğ›¼_trt=0.157 for the treatment group.
  id: totrans-19
  prefs: []
  type: TYPE_NORMAL
  zh: æˆ‘ä»¬å°†è®©ç”¨æˆ·åœ¨30å¤©å†…éšæœºåŠ å…¥å®éªŒã€‚ç”¨æˆ·çš„è½¬æ¢æ—¶é—´å°†ä»Weibullåˆ†å¸ƒä¸­æ¨¡æ‹Ÿï¼Œè§„æ¨¡å‚æ•°ğœ=30,000ï¼Œæ§åˆ¶ç»„çš„ğ›¼_ctrl=0.18ï¼Œå¤„ç†ç»„çš„ğ›¼_trt=0.157ã€‚
- en: 'Below are the corresponding survival curves:'
  id: totrans-20
  prefs: []
  type: TYPE_NORMAL
  zh: ä¸‹é¢æ˜¯å¯¹åº”çš„ç”Ÿå­˜æ›²çº¿ï¼š
- en: '[PRE0]'
  id: totrans-21
  prefs: []
  type: TYPE_PRE
  zh: '[PRE0]'
- en: '![](../Images/5692debc5db3f2bcc1739bf3a5e29f62.png)'
  id: totrans-22
  prefs: []
  type: TYPE_IMG
  zh: '![](../Images/5692debc5db3f2bcc1739bf3a5e29f62.png)'
- en: Image by author
  id: totrans-23
  prefs: []
  type: TYPE_NORMAL
  zh: å›¾ç‰‡æ¥æºï¼šä½œè€…
- en: Assuming weâ€™re interested with conversions within 7 days, the true (unknown)
    conversion rate in the control group is 19.9% and in the treatment is 23.6%.
  id: totrans-24
  prefs: []
  type: TYPE_NORMAL
  zh: å‡è®¾æˆ‘ä»¬å…³æ³¨çš„æ˜¯7å¤©å†…çš„è½¬æ¢ï¼Œæ§åˆ¶ç»„çš„çœŸå®ï¼ˆæœªçŸ¥ï¼‰è½¬æ¢ç‡ä¸º19.9%ï¼Œè€Œå¤„ç†ç»„çš„è½¬æ¢ç‡ä¸º23.6%ã€‚
- en: 'Below is the function which will generate the simulation data:'
  id: totrans-25
  prefs: []
  type: TYPE_NORMAL
  zh: ä¸‹é¢æ˜¯ç”Ÿæˆæ¨¡æ‹Ÿæ•°æ®çš„å‡½æ•°ï¼š
- en: '[PRE1]'
  id: totrans-26
  prefs: []
  type: TYPE_PRE
  zh: '[PRE1]'
- en: 'To demonstrate the benefits of using survival in A/B testing weâ€™ll compare
    the power of 3 test statistics:'
  id: totrans-27
  prefs: []
  type: TYPE_NORMAL
  zh: ä¸ºäº†å±•ç¤ºåœ¨A/Bæµ‹è¯•ä¸­ä½¿ç”¨ç”Ÿå­˜åˆ†æçš„å¥½å¤„ï¼Œæˆ‘ä»¬å°†æ¯”è¾ƒ3ç§æ£€éªŒç»Ÿè®¡é‡çš„åŠŸæ•ˆï¼š
- en: T-test on conversions (the common procedure)
  id: totrans-28
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: è½¬æ¢çš„Tæ£€éªŒï¼ˆå¸¸è§ç¨‹åºï¼‰
- en: T-test on 7 day conversion (estimated using a Kaplan-Meier curve)
  id: totrans-29
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: åŸºäº7å¤©è½¬æ¢çš„Tæ£€éªŒï¼ˆä½¿ç”¨Kaplan-Meieræ›²çº¿ä¼°ç®—ï¼‰
- en: Peto & Peto modification of the Gehan-Wilcoxon test
  id: totrans-30
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: Peto & Petoä¿®æ”¹ç‰ˆçš„Gehan-Wilcoxonæ£€éªŒ
- en: 'Below is the code that implements the above:'
  id: totrans-31
  prefs: []
  type: TYPE_NORMAL
  zh: ä¸‹é¢æ˜¯å®ç°ä¸Šè¿°å†…å®¹çš„ä»£ç ï¼š
- en: '[PRE2]'
  id: totrans-32
  prefs: []
  type: TYPE_PRE
  zh: '[PRE2]'
- en: 'Before measuring power letâ€™s verify our statistics satisfy the desired false
    positive rate ğ›¼=0.05 (5%) when both variants have the same conversion rates:'
  id: totrans-33
  prefs: []
  type: TYPE_NORMAL
  zh: åœ¨è¡¡é‡åŠŸæ•ˆä¹‹å‰ï¼Œæˆ‘ä»¬éœ€è¦éªŒè¯æˆ‘ä»¬çš„ç»Ÿè®¡é‡åœ¨ä¸¤ä¸ªå˜ä½“è½¬æ¢ç‡ç›¸åŒçš„æƒ…å†µä¸‹ï¼Œæ˜¯å¦æ»¡è¶³æœŸæœ›çš„å‡é˜³æ€§ç‡ğ›¼=0.05ï¼ˆ5%ï¼‰ï¼š
- en: '[PRE3]'
  id: totrans-34
  prefs: []
  type: TYPE_PRE
  zh: '[PRE3]'
- en: '![](../Images/3a3df2b9074fe78e55a53f0f51b9f3fe.png)'
  id: totrans-35
  prefs: []
  type: TYPE_IMG
  zh: '![](../Images/3a3df2b9074fe78e55a53f0f51b9f3fe.png)'
- en: Image by author
  id: totrans-36
  prefs: []
  type: TYPE_NORMAL
  zh: å›¾ç‰‡æ¥æºï¼šä½œè€…
- en: 'Next, letâ€™s examine power:'
  id: totrans-37
  prefs: []
  type: TYPE_NORMAL
  zh: æ¥ä¸‹æ¥ï¼Œæˆ‘ä»¬æ¥æ£€æŸ¥åŠŸæ•ˆï¼š
- en: '[PRE4]'
  id: totrans-38
  prefs: []
  type: TYPE_PRE
  zh: '[PRE4]'
- en: '![](../Images/c43d8ca5d22569d3687844f0b084d3e2.png)'
  id: totrans-39
  prefs: []
  type: TYPE_IMG
  zh: '![](../Images/c43d8ca5d22569d3687844f0b084d3e2.png)'
- en: Image by author
  id: totrans-40
  prefs: []
  type: TYPE_NORMAL
  zh: å›¾ç‰‡æ¥æºï¼šä½œè€…
- en: While the T-test on KM 7 day conversion relates better to business KPIs than
    the T-test on conversions (the common procedure), it is only marginally more powerful.
  id: totrans-41
  prefs: []
  type: TYPE_NORMAL
  zh: è™½ç„¶åŸºäºKaplan-Meieræ›²çº¿çš„7å¤©è½¬æ¢Tæ£€éªŒæ¯”å¸¸è§„çš„è½¬æ¢Tæ£€éªŒï¼ˆå¸¸è§ç¨‹åºï¼‰æ›´èƒ½ä¸ä¸šåŠ¡KPIç›¸å…³ï¼Œä½†å…¶åŠŸæ•ˆæå‡ä»…ä¸ºè¾¹é™…æ€§ã€‚
- en: The modified Gehan-Wilcoxon statistic on the other hand yields a substantial
    uplift in power, while only weakly relating to the business KPIs like the regular
    conversions T-test.
  id: totrans-42
  prefs: []
  type: TYPE_NORMAL
  zh: å¦ä¸€æ–¹é¢ï¼Œä¿®æ”¹ç‰ˆçš„Gehan-Wilcoxonç»Ÿè®¡é‡æ˜¾è‘—æå‡äº†åŠŸæ•ˆï¼ŒåŒæ—¶ä»…ä¸ä¸šåŠ¡KPIï¼ˆå¦‚å¸¸è§„çš„è½¬æ¢Tæ£€éªŒï¼‰æœ‰è¾ƒå¼±çš„ç›¸å…³æ€§ã€‚
- en: It should be noted that the power gains vary somewhat according to the point
    compared on the survival curve, the actual survival curve shape, experiment duration
    etc.
  id: totrans-43
  prefs: []
  type: TYPE_NORMAL
  zh: éœ€è¦æ³¨æ„çš„æ˜¯ï¼ŒåŠŸæ•ˆæå‡çš„ç¨‹åº¦ä¼šæ ¹æ®åœ¨ç”Ÿå­˜æ›²çº¿ä¸Šæ¯”è¾ƒçš„ç‚¹ã€å®é™…çš„ç”Ÿå­˜æ›²çº¿å½¢çŠ¶ã€å®éªŒæŒç»­æ—¶é—´ç­‰å› ç´ æœ‰æ‰€ä¸åŒã€‚
- en: In a future post I hope to further explore this topic over a wider set of scenarios
    and test statistics (The R [ComparisonSurv](https://cran.r-project.org/web/packages/ComparisonSurv/index.html?trk=article-ssr-frontend-pulse_little-text-block)
    package looks promising).
  id: totrans-44
  prefs: []
  type: TYPE_NORMAL
  zh: åœ¨æœªæ¥çš„æ–‡ç« ä¸­ï¼Œæˆ‘å¸Œæœ›åœ¨æ›´å¹¿æ³›çš„åœºæ™¯å’Œæµ‹è¯•ç»Ÿè®¡é‡ä¸‹è¿›ä¸€æ­¥æ¢è®¨è¿™ä¸ªè¯é¢˜ï¼ˆRçš„[ComparisonSurv](https://cran.r-project.org/web/packages/ComparisonSurv/index.html?trk=article-ssr-frontend-pulse_little-text-block)åŒ…çœ‹èµ·æ¥å¾ˆæœ‰å‰æ™¯ï¼‰ã€‚
- en: When doing A/B testing in scenarios where time to convert varies â€” itâ€™s often
    useful to apply survival analysis to take advantage of the time dimension. Either
    compare a point of interest on the survival curve to make the result relate directly
    to the business KPIs, or use the modified Gehan-Wilcoxon statistic statistic for
    improved power.
  id: totrans-45
  prefs: []
  type: TYPE_NORMAL
  zh: åœ¨è¿›è¡ŒA/Bæµ‹è¯•æ—¶ï¼Œå¦‚æœè½¬æ¢æ—¶é—´æœ‰æ‰€ä¸åŒâ€”â€”é€šå¸¸åº”ç”¨ç”Ÿå­˜åˆ†æä»¥åˆ©ç”¨æ—¶é—´ç»´åº¦æ˜¯éå¸¸æœ‰ç”¨çš„ã€‚å¯ä»¥æ¯”è¾ƒç”Ÿå­˜æ›²çº¿ä¸Šçš„æŸä¸ªå…´è¶£ç‚¹ï¼Œä½¿ç»“æœèƒ½å¤Ÿç›´æ¥ä¸ä¸šåŠ¡KPIç›¸å…³ï¼Œæˆ–è€…ä½¿ç”¨ä¿®æ”¹ç‰ˆçš„Gehan-Wilcoxonç»Ÿè®¡é‡ä»¥æé«˜åŠŸæ•ˆã€‚
- en: '*Originally published at* [*https://www.linkedin.com*](https://www.linkedin.com/pulse/better-ab-testing-survival-analysis-iyar-lin-o5cpf/?trackingId=fH3Lxwa%2FSEGg4WIp6DBomQ%3D%3D)*.*'
  id: totrans-46
  prefs: []
  type: TYPE_NORMAL
  zh: '*æœ€åˆå‘å¸ƒäº* [*https://www.linkedin.com*](https://www.linkedin.com/pulse/better-ab-testing-survival-analysis-iyar-lin-o5cpf/?trackingId=fH3Lxwa%2FSEGg4WIp6DBomQ%3D%3D)*.*'
